Amyloid-beta globulomer antibodies

US8497072B2 · kind B2 · utility

Assignee

• Abbott Laboratories · US

Inventors

• Heinz Hillen · Herbrechtingen, DE
• Stefan Barghorn · Mannheim, DE
• Boris Labkovsky · Framingham, US
• Ulrich Ebert · Mannheim, DE
• Andreas Striebinger · Speyer, DE
• Patrick Keller · Darmstadt, DE

Key dates

• Filing date: Nov 30, 2006
• Grant date: Jul 30, 2013
• Expiry date: Jan 22, 2027

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/2821
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.